Development asset linked to Seaport Therapeutics in public FDA and regional records.
pharma · Major Depressive Disorder (MDD), with or without Anxious Distress · Major Depressive Disorder (MDD) · SPTX
Seaport Therapeutics
Seaport Therapeutics drug portfolio — 3 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Boston, USA HQ
68 Employees
Public company Type
SPTX · NYSE Ticker
Company details
- Status
- Public
- HQ
- Boston, USA
- Employees
- 68
- Programs
- 3
- Drugs
- 3
- Patents
- 1
Seaport Therapeutics pipeline
Portfolio lens on 3 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Seaport Therapeutics drug portfolio — 3 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to Seaport Therapeutics in public FDA and regional records.
-
Development asset linked to Seaport Therapeutics in public FDA and regional records.